文献速递外周动脉疾病

优化行政数据识别外周动脉疾病患者的主要不良肢体与心血管事件

Optimizing identification of major adverse limb and cardiovascular events among adults with peripheral artery disease in administrative data.
PubMed 文献 · J Vasc Surg · 2026-04-09

本研究在单医疗系统2016-2023年间随机抽样620例成人PAD门诊患者,以五名专家三轮EHR复核的改良Delphi共识为金标准,比较行政编码策略识别长期MACE与MALE的准确性。结果显示MALE识别优于MACE,MACE仅用诊断代码优化(F1 60.3%),MALE仅用操作代码优化(F1 95.2%)。

要点

  • 行政编码可准确识别PAD患者的ASCVD结局,MALE识别优于MACE。
  • MACE识别以仅用ICD诊断代码最优,F1为60.3%。
  • MALE识别以仅用CPT操作代码最优,F1为95.2%。

核心结论

  • 行政编码可准确识别PAD患者的ASCVD结局。
  • MACE识别劣于MALE,但仅用ICD诊断代码可优化。
  • MALE识别限于操作相关事件,仅用CPT操作代码即可优化且假阴性极少。

研究设计与样本

  • 多医院单一医疗系统2016-2023年成人PAD索引血管外科门诊就诊患者。
  • 随机抽样患者对其EHR数据进行临床裁定,识别长期MACE与MALE。
  • 由五名专家经三轮EHR复核的改良Delphi流程达成共识,生成金标准诊断。
  • 共纳入620例患者,平均年龄70±12岁,40%女性,89%白人,16%衰弱。
  • 比较住院诊断(ICD)和/或操作(CPT)代码与EHR复核金标准诊断的准确性。

主要发现

  • 中位随访2.7年(四分位距1.3-4.7年)期间,临床裁定识别13% MACE和22% MALE。
  • 行政策略得出的MACE和MALE发生率与临床裁定相似。
  • MACE识别以仅用诊断代码优化,F1评分60.3%,Mathews相关系数0.55。
  • MALE识别以仅用操作代码优化,F1评分95.2%,Mathews相关系数0.94。
  • NRI在MACE为33%,在MALE为2%。

关键数值与推荐

  • MACE定义:心肌梗死、非创伤性卒中、心源性死亡。
  • MALE定义:重大血运重建、截肢。
  • MACE优化编码策略:仅用ICD诊断代码,F1 60.3%,MCC 0.55。
  • MALE优化编码策略:仅用CPT操作代码,F1 95.2%,MCC 0.94。

临床怎么用

  • 可采用行政数据编码策略量化PAD患者的MACE和MALE结局。
  • 识别MACE时优先仅用ICD诊断代码,但需注意其阳性预测值有限。
  • 识别MALE时优先仅用CPT操作代码,假阴性极少。

局限性

  • 研究为单一医疗系统,结果外推需谨慎。
  • MACE识别受阳性预测值和NRI限制,准确性低于MALE。
  • MALE识别仅限操作相关事件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Atherosclerotic cardiovascular diseases (ASCVD) are the commonest cause of death. Peripheral artery disease (PAD) is an ASCVD that significantly increases risk of death and reduces quality of life; however, characterization of its consequences is limited because it requires manual adjudication of major adverse cardiovascular events (MACEs) and major adverse limb events (MALEs). Hence, we developed and validated a system to quantify MACE and MALE using administrative data. METHODS: In a multihospital single health care system (2016-2023), we identified adult index vascular surgery clinic visits for PAD. We randomly sampled the patients for clinical adjudication of their electronic health record (EHR) data to identify long-term MACE (myocardial infarct, nontraumatic stroke, cardiac death) and MALE (major revascularization, amputation). We achieved consensus through a modified Delphi process with three rounds of EHR review by five experts, generating the gold standard diagnosis. We compared the accuracy of hospitalization diagnosis (International Classification of Diseases) and/or procedure (Current Procedural Terminology) codes to the EHR review gold standard diagnoses. Testing parameters identified the optimal administrative coding strategies when compared to the gold standard diagnoses. The predictive increment was measured by net reclassification indices (NRI). RESULTS: We included 620 patients (mean age, 70 ± 12 years; 40% female; 89% White race; 16% frail). Throughout long-term follow-up (median, 2.7 years; interquartile range, 1.3-4.7 years), clinical adjudication identified 13% MACE and 22% MALE. Administrative strategies yielded similar rates for MACE and MALE. For MACE, diagnosis-only codes optimized identification with an F1 score of 60.3% and 0.55 Mathews Correlation Coefficient. For MALE, procedure-only codes optimized identification with an F1 score of 95.2% F1 score and Matthews correlation coefficient of 0.94. The NRI was 33% for MACE and 2% for MALE. CONCLUSIONS: Administrative codes can accurately identify ASCVD outcomes among patients with PAD. MACE identification is inferior to MALE identification, but optimized with International Classification of Diseases codes only, driven by limitations in positive predictive value and NRI. MALE identification, which is limited to procedure-based events, is optimized with Current Procedural Terminology codes alone, with minimal false negatives.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Nassereldine H, Syme S, Shetty N, et al. Optimizing identification of major adverse limb and cardiovascular events among adults with peripheral artery disease in administrative data. J Vasc Surg. 2026. PMID: 41966458. doi:10.1016/j.jvs.2026.03.614

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。